Is Glenmark Life Sciences stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Glenmark Life Sciences pays dividends. Last time was Wednesday 8th of November 2023 where the investors holding the stock on Tuesday 17th of October 2023 were paid INR22.5 per share. Over the last 4 times between 2021 and 2023, Glenmark Life Sciences has paid INR64.5 with an average of INR16.13 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Glenmark Life Sciences 10 years ago, but if you had invested on Friday 6th of August 2021 when the price was INR748.50, you would have made a profit of INR402.00 per share or 53.71%
Yes, the average daily trading liquidity for Glenmark Life Sciences is INR234 226 thousand. You should therefore be able to get in and out of your positions relatively fast.
Glenmark Life Sciences has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 4.54, the company's ability to pay off the debt is good. Glenmark Life Sciences has a very good net profit margin of 20.62% and should have very high tolerances against inflation.
We have calculated the inflation risk for Glenmark Life Sciences to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.